Search for: "Astrazeneca"
Results 801 - 820
of 1,246
Sort by Relevance
|
Sort by Date
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
5 Oct 2010, 9:22 pm
., AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline - have said that they are being investigated for bribing government officials overseas to gain a larger share of business, the Wall Street Journal reports. [read post]
3 Oct 2010, 8:57 pm
Astrazeneca Pharmaceuticals LP... [read post]
2 Oct 2010, 3:23 am
ABSTRACT: By its decision of July 1, 2010 in AstraZeneca the General Court... [read post]
2 Oct 2010, 3:23 am
ABSTRACT: By its decision of July 1, 2010 in AstraZeneca the General Court... [read post]
30 Sep 2010, 8:53 am
In February, the University of Pennsylvania (Penn) and AstraZeneca forged a new collaborative research agreement, featuring a significant licensing component, that makes use of their respective talents and resources to generate new Alzheimer’s Disease (AD) drug candidates for the clinical development pipeline. [read post]
24 Sep 2010, 7:00 am
.): In this case, the SEC alleges that Self, an Executive Director of Business Development at a pharmaceutical company and Goldfield, a former hedge fund manager, engaged in unlawful insider trading in advance of the April 23, 2007 announcement that AstraZeneca would acquire MedImmune, Inc. [read post]
22 Sep 2010, 11:36 am
AstraZeneca LP, slip op. [read post]
21 Sep 2010, 7:47 pm
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
15 Sep 2010, 12:14 pm
AstraZeneca LPDocket: 10-160Issue(s): (1) Whether the lower court, when applying the Fair Labor Standards Act to the parallel Pennsylvania Minimum Wage Act, should have deferred to the Secretary of Labor’s interpretation of the Fair Labor Standards Act; and (2) whether the petitioner is covered by the administrative and outside sales exemptions of the Fair Labor Standards Act.Certiorari-Stage DocumentsOpinion below (3d Circuit)Petition for certiorariBrief in… [read post]
3 Sep 2010, 11:42 am
Interestingly, the Morgan Stanley report fingers AstraZeneca’s (“AZN’s”) CRESTOR (rosuvastatin calcium) Tablets as one drug product for which a PUC strategy may be beneficial. [read post]
1 Sep 2010, 3:48 pm
The SEC settled charges against James W. [read post]
25 Aug 2010, 6:55 am
Potentially putting controversy surrounding it’s antipsychotic drug to rest, AstraZeneca said Monday, “it has paid out to around 17,500 claimants in an amount totaling $198 million regarding allegations the drug causes diabetes in some users. [read post]
25 Aug 2010, 12:37 am
Osmotica Pharmaceutical Corp (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement suit filed following Para IV certification: Astrazeneca Pharmaceuticals LP et al. v. [read post]
22 Aug 2010, 10:16 pm
Pfizer, GlaxoSmithKline, Merck, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Baxter, SciClone are a few of the drug manufacturers that the United States Department of Justice (DOJ) is investigating for violation of bribery laws and corruption in foreign markets under the Foreign Corrupt Practices Act. [read post]
16 Aug 2010, 6:28 am
Zambri, founding member and senior attorney Bloomberg News (8/9, Feeley, Kelley) reports, "AstraZeneca Plc will pay about $198 million to settle 17,500 lawsuits, or about two-thirds of the total, alleging its antipsychotic drug Seroquel causes diabetes in some users. [read post]
11 Aug 2010, 7:01 am
" AstraZeneca's "5,500 settlements include 4,000 that AstraZeneca acknowledged in a July 29 regulatory filing. [read post]
11 Aug 2010, 4:39 am
AstraZeneca had previously agreed to pay at least $55 million to resolve more than 5,500 cases alleging the company knew Seroquel could cause diabetes and failed to adequately warn patients, people familiar with those settlements said. [read post]
10 Aug 2010, 6:10 am
Astrazeneca Pharmaceuticals LP, 585 F. [read post]
9 Aug 2010, 7:44 am
Bloomberg News (8/9, Feeley, Kelley) reports, "AstraZeneca Plc will pay about $198 million to settle 17,500 lawsuits, or about two-thirds of the total, alleging its antipsychotic drug Seroquel causes diabetes in some users. [read post]
